{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["10(5)"],"submitter":["Khan M"],"pubmed_abstract":["<h4>Background</h4>We report outcomes and novel characterization of a unique cohort of 42 individuals with persistently indeterminate human immunodeficiency virus (HIV) status, the majority of whom are HIV viral controllers.<h4>Methods</h4>Eligible individuals had indeterminate or positive HIV serology, but persistently undetectable HIV ribonucleic acid (RNA) by commercial assays and were not taking antiretroviral therapy (ART). Routine investigations included HIV Western blot, HIV viral load, qualitative HIV-1 deoxyribonucleic acid (DNA), coinfection screen, and T-cell quantification. Research assays included T-cell activation, ART measurement, single-copy assays detecting HIV-1 RNA and DNA, and plasma cytokine quantification. Human immunodeficiency virus seropositivity was defined as ≥3 "],"journal":["Open forum infectious diseases"],"pagination":["ofad108"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10155812"],"repository":["biostudies-literature"],"pubmed_title":["Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays."],"pmcid":["PMC10155812"],"pubmed_authors":["Haddow J","McClure MO","Randell P","Tosswill JHC","Alagaratnam J","Brown CS","Bradshaw D","Elliott T","Patel P","Fidler SJ","Muir D","Taylor GP","Khan M","Wang X","Mora-Peris B","Pollock K","Kaye S"],"additional_accession":[]},"is_claimable":false,"name":"Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays.","description":"<h4>Background</h4>We report outcomes and novel characterization of a unique cohort of 42 individuals with persistently indeterminate human immunodeficiency virus (HIV) status, the majority of whom are HIV viral controllers.<h4>Methods</h4>Eligible individuals had indeterminate or positive HIV serology, but persistently undetectable HIV ribonucleic acid (RNA) by commercial assays and were not taking antiretroviral therapy (ART). Routine investigations included HIV Western blot, HIV viral load, qualitative HIV-1 deoxyribonucleic acid (DNA), coinfection screen, and T-cell quantification. Research assays included T-cell activation, ART measurement, single-copy assays detecting HIV-1 RNA and DNA, and plasma cytokine quantification. Human immunodeficiency virus seropositivity was defined as ≥3 ","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 May","modification":"2025-04-05T16:13:59.045Z","creation":"2025-04-05T16:13:59.045Z"},"accession":"S-EPMC10155812","cross_references":{"pubmed":["37152187"],"doi":["10.1093/ofid/ofad108"]}}